News Releases Keyword search Year None2023202220212020201920182017201620152014201320122011201020092008 9/6/2023 AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference 8/10/2023 AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update 7/27/2023 AcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023 7/21/2023 AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules 7/18/2023 AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules 5/10/2023 AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update 4/27/2023 AcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023 4/5/2023 AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals 3/30/2023 AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update 3/21/2023 AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023 Current page 1 Page 2 Next page next › Last page last » Print Page RSS Feeds
Keyword search Year None2023202220212020201920182017201620152014201320122011201020092008 9/6/2023 AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference 8/10/2023 AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update 7/27/2023 AcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023 7/21/2023 AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules 7/18/2023 AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules 5/10/2023 AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update 4/27/2023 AcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023 4/5/2023 AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals 3/30/2023 AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update 3/21/2023 AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023 Current page 1 Page 2 Next page next › Last page last »
7/21/2023 AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules
7/18/2023 AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
5/10/2023 AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
3/30/2023 AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
3/21/2023 AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023
